NPI: 1912108002 · MISSION VIEJO, CA 92691 · General Acute Care Hospital · NPI assigned 05/29/2007
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS) |
| NPI Enumeration Date | 05/29/2007 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 91,239 | $820K |
| 2019 | 60,777 | $1.05M |
| 2020 | 67,351 | $984K |
| 2021 | 65,786 | $1.11M |
| 2022 | 84,158 | $1.49M |
| 2023 | 102,159 | $2.01M |
| 2024 | 77,063 | $2.63M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 0450 | Emergency room services | 40,414 | 34,695 | $964K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6,004 | 5,529 | $632K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 13,659 | 11,753 | $631K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7,816 | 6,675 | $409K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,990 | 1,865 | $393K |
| 70450 | Computed tomography, head or brain; without contrast material | 6,073 | 5,675 | $380K |
| 96375 | Therapeutic injection; each additional sequential IV push | 11,555 | 8,868 | $353K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3,007 | 2,982 | $341K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 17,284 | 15,189 | $326K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5,031 | 4,575 | $291K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,326 | 2,208 | $229K |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 4,061 | 2,925 | $225K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 33,905 | 27,869 | $204K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,085 | 1,007 | $201K |
| 80053 | Comprehensive metabolic panel | 23,426 | 20,264 | $199K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,995 | 2,871 | $154K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,755 | 2,300 | $152K |
| 76830 | Ultrasound, transvaginal | 2,798 | 2,678 | $151K |
| 96361 | Intravenous infusion, hydration; each additional hour | 5,756 | 4,680 | $148K |
| 83880 | 5,634 | 5,116 | $141K | |
| J3490 | Unclassified drugs | 30,300 | 10,597 | $139K |
| 71045 | Radiologic examination, chest; single view | 12,649 | 11,507 | $134K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5,814 | 4,490 | $128K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 2,612 | 1,723 | $113K |
| 99199 | Unlisted special service, procedure or report | 1,624 | 1,407 | $110K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,249 | 2,094 | $109K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 604 | 570 | $106K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3,963 | 1,023 | $106K |
| 84484 | 12,184 | 9,574 | $98K | |
| 77066 | Tomosynthesis, mammo | 680 | 675 | $97K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,593 | 1,418 | $93K |
| 93971 | 711 | 682 | $85K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 3,030 | 3,005 | $85K |
| 83690 | 12,209 | 10,658 | $64K | |
| Z7502 | 1,670 | 1,644 | $64K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,072 | 1,003 | $60K |
| Z9725 | 1,350 | 1,327 | $58K | |
| 0160 | 2,533 | 1,573 | $57K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 10,078 | 8,236 | $57K |
| 76641 | 702 | 647 | $54K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,862 | 4,413 | $51K |
| 71046 | Radiologic examination, chest; 2 views | 2,436 | 2,328 | $50K |
| 84145 | 2,516 | 2,131 | $50K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3,881 | 3,530 | $48K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 586 | 545 | $47K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 558 | 552 | $45K |
| 93976 | 902 | 867 | $42K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 437 | 400 | $38K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 1,472 | 1,280 | $36K |
| J1170 | Injection, hydromorphone, up to 4 mg | 6,948 | 4,150 | $36K |
| 73630 | 1,633 | 1,485 | $36K | |
| 93970 | 157 | 151 | $36K | |
| 76801 | 576 | 522 | $35K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 476 | 471 | $35K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 287 | 254 | $34K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 308 | 277 | $33K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 11,103 | 7,942 | $33K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,778 | 4,350 | $29K |
| 81001 | 12,328 | 11,147 | $29K | |
| 76642 | 446 | 443 | $29K | |
| 87040 | 2,940 | 1,929 | $28K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 913 | 909 | $28K |
| 82553 | 3,852 | 3,290 | $28K | |
| 83605 | 3,263 | 2,714 | $28K | |
| 0760 | 1,700 | 1,362 | $26K | |
| 83735 | 5,319 | 4,247 | $26K | |
| 72131 | 373 | 334 | $25K | |
| 90715 | 746 | 711 | $24K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 825 | 761 | $23K |
| 73562 | 1,005 | 894 | $22K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,266 | 945 | $21K |
| 82550 | 4,907 | 4,138 | $21K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 6,799 | 5,314 | $21K |
| 72100 | 842 | 814 | $21K | |
| 73030 | 949 | 875 | $20K | |
| 70486 | 236 | 232 | $20K | |
| 71250 | 223 | 200 | $20K | |
| 84702 | 3,373 | 3,055 | $20K | |
| 97750 | 318 | 280 | $19K | |
| 73610 | 874 | 814 | $19K | |
| 87631 | 422 | 348 | $19K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 119 | 107 | $17K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 718 | 502 | $17K |
| 85379 | 2,026 | 1,909 | $15K | |
| 85610 | 5,373 | 4,791 | $14K | |
| 84703 | 5,929 | 5,449 | $14K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,432 | 1,728 | $13K |
| 80076 | 2,438 | 2,163 | $13K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 151 | 149 | $13K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 327 | 297 | $12K |
| 59025 | Fetal non-stress test | 863 | 325 | $12K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 65 | 58 | $12K |
| 77065 | Tomosynthesis, mammo | 109 | 100 | $11K |
| 77080 | 307 | 307 | $11K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,634 | 1,719 | $11K |
| 85730 | 2,883 | 2,640 | $11K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,918 | 2,241 | $10K |
| 73130 | 460 | 429 | $10K | |
| 85027 | 2,166 | 1,812 | $10K | |
| J2704 | Injection, propofol, 10 mg | 1,635 | 1,243 | $10K |
| J2060 | Injection, lorazepam, 2 mg | 3,102 | 2,091 | $10K |
| 80047 | 2,069 | 1,871 | $10K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,659 | 2,009 | $9K |
| 72141 | 87 | 75 | $9K | |
| A9585 | Injection, gadobutrol, 0.1 ml | 372 | 315 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 918 | 884 | $8K |
| 81025 | 2,362 | 2,171 | $8K | |
| 72128 | 136 | 117 | $8K | |
| 87077 | 994 | 903 | $7K | |
| 86901 | 3,072 | 2,818 | $7K | |
| 81003 | 6,694 | 6,122 | $7K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 967 | 782 | $7K |
| 86900 | 3,070 | 2,816 | $7K | |
| 70496 | 25 | 24 | $6K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 75 | 73 | $6K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 657 | 608 | $6K |
| 86140 | 1,540 | 1,280 | $6K | |
| 87186 | 903 | 833 | $6K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,675 | 1,394 | $6K |
| J0690 | Injection, cefazolin sodium, 500 mg | 969 | 746 | $6K |
| 94760 | 1,359 | 778 | $5K | |
| 0270 | 32,968 | 12,846 | $5K | |
| 86850 | 2,101 | 1,933 | $5K | |
| 97139 | 356 | 41 | $5K | |
| 87081 | 1,269 | 1,158 | $5K | |
| 73110 | 231 | 210 | $5K | |
| 82150 | 1,630 | 1,498 | $5K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,862 | 1,433 | $5K |
| 96376 | 5,128 | 3,308 | $4K | |
| 84100 | 1,311 | 996 | $4K | |
| 82947 | 2,415 | 1,553 | $3K | |
| 80143 | 136 | 127 | $3K | |
| 80179 | 133 | 126 | $3K | |
| 74018 | 230 | 208 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 774 | 725 | $3K |
| A4217 | Sterile water/saline, 500 ml | 503 | 460 | $3K |
| J7050 | Infusion, normal saline solution, 250 cc | 531 | 228 | $3K |
| S0164 | Injection, pantoprazole sodium, 40 mg | 374 | 241 | $3K |
| 85652 | 1,178 | 1,057 | $2K | |
| J3411 | Injection, thiamine hcl, 100 mg | 200 | 138 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 270 | 259 | $2K |
| 93017 | 44 | 40 | $2K | |
| J2785 | Injection, regadenoson, 0.1 mg | 13 | 13 | $2K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 225 | 194 | $2K |
| 97802 | 14 | 14 | $2K | |
| J1815 | Injection, insulin, per 5 units | 73 | 51 | $2K |
| G0202 | Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 42 | 42 | $2K |
| 76536 | 33 | 32 | $1K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 143 | 96 | $1K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 611 | 430 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 180 | 127 | $1K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 170 | 89 | $1K |
| 96367 | 46 | 25 | $1K | |
| 85007 | 640 | 540 | $1K | |
| 84439 | 174 | 158 | $937.57 | |
| 86141 | 230 | 211 | $931.83 | |
| J1644 | Injection, heparin sodium, per 1000 units | 205 | 108 | $922.53 |
| 71020 | 48 | 47 | $898.92 | |
| J3535 | Drug administered through a metered dose inhaler | 40 | 38 | $892.95 |
| 71010 | 118 | 112 | $818.95 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 831 | 758 | $811.14 |
| 73590 | 40 | 38 | $755.90 | |
| 76770 | 12 | 12 | $741.00 | |
| 87205 | 351 | 308 | $736.30 | |
| 73080 | 30 | 26 | $702.46 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 135 | 65 | $698.31 |
| 72170 | 47 | 40 | $691.58 | |
| Z7610 | 126 | 64 | $659.75 | |
| 85014 | 744 | 618 | $608.79 | |
| 76870 | 13 | 13 | $598.39 | |
| 73502 | 16 | 16 | $568.41 | |
| 87420 | 176 | 170 | $540.64 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 136 | 129 | $529.62 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 114 | 81 | $529.20 |
| 87070 | 144 | 127 | $509.35 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 17 | 14 | $486.80 |
| J3360 | Injection, diazepam, up to 5 mg | 44 | 36 | $445.82 |
| 72040 | 12 | 12 | $444.47 | |
| 0250 | 1,199 | 574 | $383.47 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 44 | 42 | $382.80 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 42 | 38 | $326.50 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 41 | 37 | $319.50 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 12 | 12 | $309.60 |
| 0710 | 951 | 881 | $287.42 | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 49 | 29 | $270.41 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 32 | 19 | $248.00 |
| 82077 | 24 | 23 | $228.55 | |
| 0258 | 706 | 449 | $191.06 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 72 | 56 | $189.05 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 290 | 261 | $185.54 |
| 82248 | 60 | 53 | $182.23 | |
| 0761 | 226 | 191 | $170.50 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 71 | 60 | $170.43 |
| 87430 | 46 | 46 | $170.04 | |
| 10060 | 17 | 16 | $165.00 | |
| 80061 | Lipid panel | 53 | 53 | $164.62 |
| 99070 | 284 | 140 | $160.04 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 74 | 55 | $156.69 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 36 | 25 | $154.79 |
| 82728 | 32 | 27 | $148.80 | |
| 0360 | 524 | 410 | $146.17 | |
| 83615 | 41 | 31 | $125.15 | |
| 0272 | 829 | 530 | $120.80 | |
| J3480 | Injection, potassium chloride, per 2 meq | 18 | 15 | $113.36 |
| 12001 | 13 | 12 | $112.80 | |
| 80050 | General health panel | 94 | 56 | $103.95 |
| 87147 | 38 | 37 | $103.11 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 33 | 24 | $67.70 |
| 99152 | 15 | 12 | $65.31 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 12 | 12 | $63.65 |
| 87075 | 13 | 13 | $57.94 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 381 | 362 | $57.50 |
| 87210 | 23 | 16 | $45.94 | |
| 0637 | 50 | 23 | $39.62 | |
| 86308 | 13 | 13 | $32.31 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 551 | 237 | $29.56 |
| 94664 | 75 | 69 | $24.68 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 8,154 | 5,590 | $16.81 |
| S0028 | Injection, famotidine, 20 mg | 134 | 104 | $8.84 |
| 0636 | 266 | 138 | $0.00 | |
| 0307 | 80 | 71 | $0.00 | |
| 0305 | 121 | 76 | $0.00 | |
| 0352 | 99 | 72 | $0.00 | |
| 0301 | 821 | 222 | $0.00 | |
| 0350 | 14 | 13 | $0.00 | |
| 0324 | 114 | 108 | $0.00 | |
| C9399 | Unclassified drugs or biologicals | 26 | 25 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 17 | 13 | $0.00 |
| 0306 | 180 | 102 | $0.00 | |
| 0922 | 12 | 12 | $0.00 | |
| C1769 | Guide wire | 16 | 12 | $0.00 |
| 0949 | 67 | 22 | $0.00 | |
| 77062 | 125 | 125 | $0.00 | |
| 0300 | 513 | 212 | $0.00 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 30 | 29 | $0.00 |
| 0351 | 58 | 48 | $0.00 | |
| 0762 | 317 | 305 | $0.00 | |
| 0403 | 40 | 20 | $0.00 | |
| 0302 | 28 | 26 | $0.00 | |
| 0402 | 154 | 98 | $0.00 | |
| 0320 | 116 | 86 | $0.00 | |
| 0489 | 16 | 12 | $0.00 |